Quarterly report pursuant to Section 13 or 15(d)

Revenues from Contracts and Significant Customers (Tables)

v3.10.0.1
Revenues from Contracts and Significant Customers (Tables)
 6 Months Ended
Jun. 30, 2018
Disaggregation of Revenue
The Company has three marketed products, Targadox®, Luxamend® and Ceracade. Substantially all of the Company’s product revenues are recorded in the U.S. Substantially all of the Company’s collaboration revenues are from its collaboration with TGTX. Revenues by product and collaborator are summarized as follows (in thousands):
 
 
 
Three months ended
June 30, 2018
 
Six months ended
June 30, 2018
 
Targadox®
 
$
6,363
 
$
11,861
 
Other branded revenue
 
 
326
 
 
337
 
Total product revenues
 
$
6,689
 
$
12,198
 
TGTX
 
 
126
 
 
520
 
Total Revenue
 
$
6,815
 
$
12,718
 
Revenue From Contracts With Customers [Member]  
Disaggregation of Revenue
The following presents National’s revenues from contracts with customers disaggregated by major business activity for the three months ended June 30, 2018:
 
($ in thousands)
 
For the Three
Months Ended
June 30, 2018
 
For the Six
Months Ended
June 30, 2018
 
Revenues from customer contracts:
 
 
 
 
 
 
 
Commissions
 
$
31,407
 
$
57,025
 
Investment banking:
 
 
 
 
 
 
 
Underwriting
 
 
6,893
 
 
9,593
 
Private placement
 
 
3,484
 
 
13,299
 
Advisory
 
 
833
 
 
2,147
 
Other
 
 
(4)
 
 
156
 
Sub-total National revenue from contracts with customers
 
 
42,613
 
 
82,220
 
Other National revenue
 
 
14,406
 
 
24,321
 
Total National revenue
 
$
57,019
 
$
106,541